Trials (Sahlgrenska University Hospital): Revision history

15 December 2025

• curprev 16:4916:49, 15 December 2025‎ Francine talk contribs‎ 297,910 bytes +218‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 297,692 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:0517:05, 4 December 2025‎ Larysse talk contribs‎ 295,991 bytes +48‎ No edit summary undo

2 December 2025

• curprev 14:0014:00, 2 December 2025‎ Lucas talk contribs‎ m 295,943 bytes +90‎ Update categories. undo

5 December 2023

• curprev 17:5017:50, 5 December 2023‎ Francine talk contribs‎ 295,853 bytes +295,853‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Sahlgrenska University Hospital page '''NCTID''': NCT03685890 '''Title''': Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion '''Study Summary''': To evaluate safety and the effect of isolated limb perfusion together with nivolumab as a way to increase efficacy and give further insights in early immunological mechanisms. In the first phase..."